Eosinophilia during Psoriasis Treatment with TNF Antagonists (original) (raw)
Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumab
Ioanna Lefaki
Annals of the Rheumatic Diseases, 2006
View PDFchevron_right
Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab: Table 1
Daniela Marasović Krstulović
Rheumatology, 2015
View PDFchevron_right
Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A
Rudolf Schopf
Journal of the European Academy of Dermatology and Venereology, 1998
View PDFchevron_right
PRACTITIONER ’ S CORNER Subacute Prurigo and Eosinophilia in a Patient With Rheumatoid Arthritis Receiving Infl iximab and Etanercept
N. Cancelliere
2011
View PDFchevron_right
Subacute prurigo and eosinophilia in a patient with rheumatoid arthritis receiving infliximab and etanercept
N. Cancelliere
Journal of investigational allergology & clinical immunology, 2011
View PDFchevron_right
Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease: A Case Report
Anita Lee
Annals of internal medicine, 2017
View PDFchevron_right
Efalizumab in the treatment of psoriasis: when comorbidity is an issue
Francesca Prignano
Dermatologic Therapy, 2008
View PDFchevron_right
The Role of Benralizumab in Eosinophilic Immune Dysfunctions: A Case Report-Based Literature Review
Ana Mendes
Case Reports in Medicine
View PDFchevron_right
Severe Toxic Epidermal Necrolysis and Drug Reaction with Eosinophilia and Systemic Symptoms Overlap Syndrome Treated with Benralizumab: A Case Report
Patrick Bader
Case Reports in Dermatology, 2022
View PDFchevron_right
Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases
Yannick Elshot
Melanoma Research, 2023
View PDFchevron_right
Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis
Franck Delesalle
Arthritis and Rheumatism, 2008
View PDFchevron_right
Adverse reactions of biological therapies in patients with psoriasis
ALEXANDRA LIMBAU
Journal of Mind and Medical Sciences, 2017
View PDFchevron_right
Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab
B. Laganà
International journal of immunopathology and pharmacology
View PDFchevron_right
Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab
Yu-min Kuo
Journal of Clinical Pharmacy and Therapeutics, 2008
View PDFchevron_right
Mepolizumab as a steroid-sparing treatment option in a patient with eosinophilic granulomatosis with polyangiitis
Ana Rita Presa
Arquivos de Asmas Alergia e Imunologia, 2021
View PDFchevron_right
Wells syndrome in a patient receiving adalimumab biosimilar: A case 18. Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, et al. Eosinophilia – A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis. J Dermatolog Treat 2016;27:110-3. r...
Bishandas Radotra
Indian Journal of Dermatology, Venereology and Leprology, 2018
View PDFchevron_right
Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
Davide Zanon
Journal for ImmunoTherapy of Cancer
View PDFchevron_right
Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
Susanna Bormioli
Allergy, Asthma & Immunology Research
View PDFchevron_right
Eosinophilic annular erythema showing eosinophil cytolytic ETosis successfully treated with benralizumab
Katsunori Masaki
Asia Pacific Allergy, 2021
View PDFchevron_right
Paradoxical Reaction to Golimumab: Tumor Necrosis Factor a Inhibitor Inducing Psoriasis Pustulosa
Rachel Grynszpan
Case Reports in Dermatology, 2013
View PDFchevron_right
Lack of Anti-drug Antibodies in Patients with Psoriasis Well-controlled on Long-term Treatment with Tumour Necrosis Factor Inhibitors
C. Zachariae
Acta Dermato Venereologica, 2012
View PDFchevron_right
Efalizumab in Psoriasis: Our Experience with 11 Patients~!2010-01-28~!2010-05-10~!2010-06-11~!
Aurora Guerra
The Open Dermatology Journal, 2010
View PDFchevron_right
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases
Salvador J Diaz-Cano
British Journal of Dermatology
View PDFchevron_right
A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents
Francisco Tausk
Annals of the Rheumatic Diseases, 2006
View PDFchevron_right
Adverse reactions of biological therapy for psoriasis
Andreea Dimitriu
2015
View PDFchevron_right
Adalimumab induced severe paradoxical psoriasis in a patient with ankylosing spondylitis
Pınar Karabağlı
Cukurova Medical Journal, 2022
View PDFchevron_right
Efalizumab-Associated Papular Psoriasis
Saad Hassan
Archives of Dermatology, 2007
View PDFchevron_right
Psoriasiform Reactions to Anti–Tumor Necrosis Factor α Therapy
Khang Nguyễn
Journal of Clinical Rheumatology, 2013
View PDFchevron_right